Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs

Targeting of drugs and nanoparticles to tumors

(2010) Erkki Ruoslahti et al.   JOURNAL OF CELL BIOLOGY

Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors

(2009) Kazuki N. Sugahara et al.   CANCER CELL

Is Anticancer Drug Development Heading in the Right Direction?

(2009) Trevor W. Hambley   CANCER RESEARCH

C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration

(2009) T. Teesalu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Systematic Surface Engineering of Magnetic Nanoworms for In vivo Tumor Targeting

(2009) Ji-Ho Park et al.   Small

Neuropilins: structure, function and role in disease

(2008) Caroline Pellet-Many et al.   BIOCHEMICAL JOURNAL

Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor

(2008) L. M. Acevedo et al.   BLOOD

The role of doxorubicin and epirubicin in the treatment of patients with metastatic hormone-refractory prostate cancer

(2008) Roberto Petrioli et al.   CANCER TREATMENT REVIEWS

Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin

(2008) F. Pastorino et al.   CLINICAL CANCER RESEARCH

Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis

(2008) E. A. Murphy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA